Guardion Health Sciences, Inc. (GHSI)
NASDAQ: GHSI · IEX Real-Time Price · USD
+0.01 (0.12%)
At close: May 17, 2024, 4:00 PM
+0.15 (1.76%)
After-hours: May 17, 2024, 7:55 PM EDT

Guardion Health Sciences Revenue

Guardion Health Sciences had revenue of $12.06M in the twelve months ending March 31, 2024, with 1.79% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.00M, a -5.84% decrease year-over-year. In the year 2023, Guardion Health Sciences had annual revenue of $12.25M with 10.85% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
10.93M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202312.25M1.20M10.85%
Dec 31, 202211.05M3.82M52.77%
Dec 31, 20217.23M5.34M282.74%
Dec 31, 20201.89M986.91K109.30%
Dec 31, 2019902.94K-39.22K-4.16%
Dec 31, 2018942.15K504.80K115.42%
Dec 31, 2017437.35K296.32K210.11%
Dec 31, 2016141.03K28.22K25.01%
Dec 31, 2015112.81K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareMax 810.36M
Trinity Biotech 56.83M
iCoreConnect 9.03M
Genetic Technologies 5.78M
Akanda 2.16M
Can-Fite BioPharma 743.00K
BioCardia 468.00K
ABVC BioPharma 152.43K
Revenue Rankings